Orosomucoid-1 Expression in Ameloblastoma Variants.
Alejandro García-Muñoz(Universidad Juárez del Estado de Durango), Rogelio González‐González(Universidad de la República de Uruguay), Rodrigo Liceága-Reyes(Hospital Juárez de México), José Eduardo Farfán-Morales(Instituto Nacional de Pediatria), Mario A. Rodríguez(Cordoba University), Ronell Bologna‐Molina(Universidad de la República de Uruguay), Saray Aranda‐Romo(Autonomous University of San Luis Potosí), Nelly Molina‐Frechero(Universidad Autónoma Metropolitana)
PubMed
January 1, 2016
Cited by 2
Related Papers
Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors
|Medicina oral, patología oral y cirugía bucal|2012|253
Extranodal NK/T cell lymphoma, nasal type: An updated overview
|Critical Reviews in Oncology/Hematology|2021|111
Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas
|Oral Oncology|2008|83
Comparative expression of syndecan‐1 and Ki‐67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma
|Pathology International|2009|62
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
|World Journal of Clinical Oncology|2019|58